Pharmacists in Danville, California


45 Pharmacists found in Danville
female pharmacist

Mrs. Sheng Jen Shen


Pharmacist
480 Diablo Rd, Danville, CA 94526
925-855-8145     925-855-8151

female pharmacist

Shilpa Adlapalli


Pharmacist
650 San Ramon Valley Blvd, Danville, CA 94526
925-820-3222    

female pharmacist

Soh Joung Kim, PHARMD


Pharmacist
611 San Ramon Valley Blvd, Danville, CA 94526
925-743-0166    



male pharmacist

Dr. Stanley K Leong, PHARM D


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
3150 Fostoria Way, Danville, CA 94526
925-277-1800    

female pharmacist

Thanh Kim Luu, PHARMD


Pharmacist
611 San Ramon Valley Blvd, Danville, CA 94526
925-743-0166     925-743-0796

female pharmacist

Dr. Tien Lie, PHARM.D.


Pharmacist
480 Diablo Rd, Danville, CA 94526
925-855-8145     925-855-8151

female pharmacist

Dr. Tina Bhateja, PHARMD


Pharmacist
302 Ilo Ln, Danville, CA 94526
925-818-3150    

female pharmacist

Valerie Gong, PHARM D


Pharmacist
3150 Fostoria Way, Danville, CA 94526
925-277-1800    

male pharmacist

Dr. Vinh Ly, PHARM. D.


Pharmacist
335 Glasgow Cir, Danville, CA 94526
925-314-9838    

female pharmacist

Ms. Wafa Samara, RPH


Pharmacist
30 Stanton Ct, Danville, CA 94506
925-372-2588    

male pharmacist

William Brian Jeha, RPH


Pharmacist
3496 Camino Tassajara, Danville, CA 94506
925-736-0346     925-736-0327

female pharmacist

Ya-ching Lu


Pharmacist
650 San Ramon Valley Blvd, Danville, CA 94526
925-820-3222    

male pharmacist

Dr. Yu An Cho, PHARMD


Pharmacist
3496 Camino Tassajara, Danville, CA 94506
925-736-0346    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.